Home < Scientific Library < Abstract < Percutaneous LAA Occlusion < 

Percutaneous LAA Occlusion

Clinical Trial

2021 Feb 16;143(7):673-684.

JOURNAL:Circulation.

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

TA Zelniker, M Ardissino, F Andreotti et al.

7224

Keywords: AF; AMI with atrial fibrillation and CHADS2 score ≥2; higher-dose edoxaban vs.lower-dose edoxaban regimen; warfarin; gender difference

Full Text PDF